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Summary Despite signiﬁcant improvements in tuberculosis (TB) management under the WHO
directly observed treatment, short course (DOTS) strategy, childhood TB has been relatively
neglected. Children are at high risk of severe disease, and reactivation of latent infection in
adulthood perpetuates the epidemic. Almost a million cases of childhood TB are estimated toEpidemiology;
DOTS;
HIV
occur annually, but good-quality epidemiological data are scarce due to inherent difﬁculties
diagnosing paediatric TB. There remains an urgent need both for better diagnostic tests and
for robust regional data on the true burden of disease, otherwise childhood TB will remain an
essentially ‘invisible’ and therefore neglected disease.
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Tuberculosis (TB) has been propelled to the forefront of the
international health agenda in the wake of the HIV/AIDS
epidemic and the evolution of multidrug-resistant (MDR)
and extensively drug-resistant (XDR) strains, stimulating
a wide portfolio of research, and injecting new vigour
into public health strategies to control the disease. Fol-
lowing the WHO declaration of a global TB emergency in
1993, the directly observed treatment, short course (DOTS)
strategy was launched, underpinned by ﬁve key elements:
sustained political commitment; improved case detection
through quality assured bacteriology; standardized short
course treatment; assured drug supply; and standardized
monitoring and evaluation. Now implemented in nearly 200
countries, DOTS has already led to signiﬁcant improvements
in case detection and treatment outcomes.
Childhood TB, however, has been relatively neglected.
The emphasis placed by DOTS on detection of smear-
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doi:10.1016/j.trstmh.2007.09.011ositive cases (which are most infectious) does not address
he situation in children, the vast majority of whom have
mear-negative disease. In wealthier, low-burden countries,
nfected children are often identiﬁed by contact tracing
nd given chemoprophylaxis, but limited resources and a
uch higher disease incidence prohibit this in most high-
urden settings. Until recently, most national tuberculosis
rogrammes (NTPs) did not collect data on paediatric TB
y age and clinical syndrome, reﬂecting its perceived lower
riority.
TB nevertheless remains an important and potentially
reventable cause of childhood illness and death. Young chil-
ren have a high risk of progression to disease following
nfection, and are much more likely to develop severe or
isseminated TB. Children with latent tuberculosis infection
LTBI) become the reservoir of future disease in adulthood,
erpetuating the epidemic. The HIV epidemic, which dis-
roportionately affects young adults, many of whom are
o-infected with TB, may also put their children at partic-
larly high risk of infection. Observational data do suggest
disproportionately higher paediatric caseload where dete-
iorating socioeconomic conditions are accompanied by a
e and Hygiene. Published by Elsevier Ltd. All rights reserved.
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igher overall incidence of TB, and children account for
ore than 20% of TB cases in some high-burden settings.
Worldwide there were nearly a million estimated new
ases of childhood TB in 2000 (Nelson and Wells, 2004),
ut reliable data on the burden of childhood TB remain
carce in most high-burden settings. This is partly due to
nherent difﬁculties in diagnosing paediatric TB. In children
he clinical and radiological features of TB overlap those of
ther common childhood diseases, particularly where HIV
nd malnutrition (two of the most important risk factors)
re endemic. Crucially, a deﬁnitive microbiological diagno-
is is achieved in only a minority of cases, as young children
arely develop cavitatory lung disease or expectorate spu-
um, and a greater proportion of cases are extrapulmonary.
iagnosis therefore usually relies on poorly validated clinical
ase deﬁnitions, and both under- and over-diagnosis of pae-
iatric TB are common, with potentially tragic consequences
or children who are not diagnosed.
Despite the scale of the problem, progress developing
etter diagnostics has been slow. Serological assays have
o far proved disappointing, and nucleic acid ampliﬁcation
ests for Mycobacterium tuberculosis still lack sensitivity;
FN- release assays appear to perform better than tuber-
ulin skin testing, but do not differentiate active TB from
TBI (Dinnes et al., 2007). All currently remain too complex
nd expensive for use at the point of care in resource-poor
ettings. There remains, therefore, an urgent need for a
apid, reliable and affordable diagnostic test, and it is essen-
ial that any such test be properly validated in children.
trategies currently being explored include a urinary anti-
en test for mycobacterial lipoarabinomannan, the search
or disease biomarkers using gene array and proteomic tech-
ology, and combinations of existing tests.
Better diagnostics are not the only challenge, however.
ther priorities include the need for better, particularly
horter, treatment regimens; improved case management,
ontact tracing and delivery of chemoprophylaxis in low-
esource settings; and the search for a new vaccine. Perhaps
ost importantly, there is a real need for prospective epi-
emiological studies to determine the true burden of TB
mong children in a wide spectrum of settings worldwide.
ecent WHO guidance has already taken a signiﬁcant step
n this direction by recommending NTPs record childhood
N
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B cases by age category and clinical syndrome (WHO,
006). Further high-quality studies underpinned by active
ase ascertainment and post mortem data are nevertheless
equired. TB does not currently feature per se in WHO esti-
ates of the causes of death in children (Bryce et al., 2002);
et pneumonia accounts for over 4 million deaths each year
n Africa alone, and one necropsy study from Zambia found
vidence of TB in nearly 20% of HIV-positive and 26% of HIV-
egative children dying of pneumonia (Chintu et al., 2002).
s new candidate TB vaccines approach clinical trials, good-
uality epidemiological data will be essential to assess their
fﬁcacy, cost-effectiveness and optimum vaccine schedules.
bove all, without robust regional data on the true bur-
en of disease to inform public health policy, childhood TB
ill remain an essentially ‘invisible’ and therefore neglected
isease.
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